ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL FORMULATION DEVELOPMENT

Artificial Intelligence (AI) is emerging as a transformative technology in pharmaceutical formulation development by improving the efficiency, accuracy, and speed of drug development processes. Traditional formulation development involves time-consuming experiments, extensive laboratory investigations, and trial-and-error approaches to identify suitable ingredients and optimize formulation parameters. AI-based techniques, including machine learning, deep learning, artificial neural networks, and predictive modelling, offer innovative solutions to overcome these challenges. These technologies can analyze large datasets, predict drug–excipient interactions, optimize formulation compositions, and evaluate critical quality attributes of pharmaceutical products. AI also plays an important role in selecting appropriate excipients, predicting drug solubility, dissolution profiles, stability, and bioavailability, thereby supporting the development of safe, effective, and high-quality drug formulations. Furthermore, the integration of AI with Quality by Design (QbD), process analytical technology (PAT), and continuous manufacturing can enhance process optimization and reduce development costs. AI-driven approaches have potential applications in the development of tablets, capsules, nanoparticles, liposomes, controlled-release systems, and other advanced drug delivery systems. Despite its significant advantages, challenges such as data quality, model validation, regulatory acceptance, and implementation costs need to be addressed. Overall, artificial intelligence represents a promising approach to modernizing pharmaceutical formulation development by enabling faster decision-making, reducing experimental workload, and supporting the development of innovative and personalized drug delivery systems. Keywords: Artificial Intelligence, Pharmaceutical Formulation, Machine Learning, Deep Learning, Drug Delivery Systems, Quality by Design, Formulation Optimization.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-17
DOI
https://doi.org/10.5281/zenodo.24316931
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL FORMULATION DEVELOPMENT

Sk. Afrin V.Vasu Naik*
2 links
Zenodo (CERN European Organization for Nuclear Research)
Computational Drug Discovery Methods
article

ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL FORMULATION DEVELOPMENT

Sk. Afrin V.Vasu Naik*
article en

Abstract

Artificial Intelligence (AI) is emerging as a transformative technology in pharmaceutical formulation development by improving the efficiency, accuracy, and speed of drug development processes. Traditional formulation development involves time-consuming experiments, extensive laboratory investigations, and trial-and-error approaches to identify suitable ingredients and optimize formulation parameters. AI-based techniques, including machine learning, deep learning, artificial neural networks, and predictive modelling, offer innovative solutions to overcome these challenges. These technologies can analyze large datasets, predict drug–excipient interactions, optimize formulation compositions, and evaluate critical quality attributes of pharmaceutical products. AI also plays an important role in selecting appropriate excipients, predicting drug solubility, dissolution profiles, stability, and bioavailability, thereby supporting the development of safe, effective, and high-quality drug formulations. Furthermore, the integration of AI with Quality by Design (QbD), process analytical technology (PAT), and continuous manufacturing can enhance process optimization and reduce development costs. AI-driven approaches have potential applications in the development of tablets, capsules, nanoparticles, liposomes, controlled-release systems, and other advanced drug delivery systems. Despite its significant advantages, challenges such as data quality, model validation, regulatory acceptance, and implementation costs need to be addressed. Overall, artificial intelligence represents a promising approach to modernizing pharmaceutical formulation development by enabling faster decision-making, reducing experimental workload, and supporting the development of innovative and personalized drug delivery systems. Keywords: Artificial Intelligence, Pharmaceutical Formulation, Machine Learning, Deep Learning, Drug Delivery Systems, Quality by Design, Formulation Optimization.

Zenodo (CERN European Organization for Nuclear Research)
Industry, innovation and infrastructure, Good health and well-being
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon